Last thoughts ahead of the EUCO videoconference

Macro

Christopher Dembik

Head of Macro Analysis

Summary:  Tonight, EU leaders will discuss the latest health and economic response to the COVID-19 outbreak. We don't expect any major achievements regarding coronabonds due to the strong opposition of Austria, Germany and the Netherlands. In these countries, debt mutualisation is anathema. Most of the discussion should be about activating or not the ESM credit line. At the occasion of the videoconference, the EU could announce the creation of a permanent European Crisis Management Centre.


The EUCO videoconference will focus on four major themes:

  • Limiting the spread of the virus
  • Providing medical equipment, with a focus on masks and respirators
  • Promoting research into a vaccine
  • Discussing solutions to mitigate the socio-economic consequences

We expect a technical discussion with no final decision about the EC proposal for an European employment reinsurance that would top up national schemes.

The EU might confirm the creation of a permanent European Crisis Management Centre in order to better coordinate the EU health response in the future.

EU leaders will lengthily discuss two major stumbling blocks:

1. The ESM emergency credit line (for more details on that point, please read our report focusing on the latest Eurogroup meeting).

The Dutch finance minister has been the most vocal opponents against activating the ESM credit line as a first emergency response for member states in need. A technical aspect, that also matters a lot politically, will need to be clarified: it is still unclear whether to attach or not conditionality to ESM credit line. It will certainly be of prime importance to lift conditionality or to soften it (i.e. making sure that the credit line is only used to cope with the effect of the COVID-19 outbreak) to gain support from Italy, Spain and France. We are carefully optimistic that an agreement can be reached either tonight or at the next EUCO videconference.

2.  Coronabonds (for more insights, see our latest report Coronavirus Economics: The case for coronabonds).

Inherited divisions from the past crisis seem to prevent the launch of coronabonds for the moment. The below map, courtesy of our graphic designer Julie, shows EU countries’ support to coronabonds. Germany, the Netherlands and Austria have clearly repeated over the past few days their strong opposition to this new instrument. Yesterday, France, Italy, Spain and six other euro area governments signed a letter in favor of their implementation. In a last move ahead of the EUCO videoconference scheduled tonight, the Austrian PM rejected one more time the perspective of common EU issuance. Being realistic, we don’t see much what could unlock negotiations tonight. Given that a large part of the videoconference will be probably devoted to the ESM credit line, which will already lead to tough talks, it is likely that EU leaders will barely examine the possibility of coronabonds. This issue is likely to be discussed later.

On a final note, there has been a lot of noise over the past 24 hours about tools that the ECB could use to help countries in disarray. Yesterday, the ECB said to be “broadly in favor of activating OMT if needed”. In our view, the OMT program is certainly not the most adequate instrument to deploy in the current crisis due to its lack of flexibility (i.e. the ECB can only buy government-issued bonds that mature in 1 to 3 years). Unless OMT modalities can be changed, which is far from certain, it makes much more sense to adopt a multi-tool approach including ESM purchase (or ideally coronabonds administrated by the ESM) and PEPP (the ECB’s Pandemic Emergency Purchase Program).

Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.